GSE186507

Blood expression profiling of an adult inflammatory bowel disease cohort

Whole-study status Not suitable

Dataset does not meet the current suitability threshold.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

821 case / 209 control samples elsewhere in the study have incomplete or conflicting evidence; they are not included above

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Source
GEO
Assay
bulk RNA-seq
Organism
Homo sapiens
Whole-study samples
1030 samples
Specimen
Biofluid
Reported/interpreted study design
Disease/model vs control Design classification does not establish patient pairs.
Comparison type
Tumor vs normal
Contributors
Argmann C, Suárez-Fariñas M, Hou R, Irizar A
Contact name
Carmen argmann
Submission date
2021-10-25
Last update
2024-11-04
Organization
MSSM
Department
Not available
Public date
2022-09-16
Experiment types
Expression profiling by high throughput sequencing
Platforms
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
Series type
Series
SubSeries
Not available
BioProject
PRJNA774251

Summary

Inflammatory Bowel Disease (IBD) is a progressive disease of the gut and consists of two types, Crohn’s Disease (CD) and Ulcerative Colitis (UC). It is a complex disease involving genetic, microbial, and environmental factors. The incidence of IBD is steadily increasing and current therapeutic options are plateauing. Thus treatments are evolving to 1. deeper levels of remission from clinical to endoscopic and histologic normalization and 2. Embrace novel targets or drug combinations. We explored whole transcriptome data generated in blood specimens sampled from a large cohort of adult IBD and control subjects to provide 1. a granular, objective and sensitive molecular measures of disease activity in the gut and 2. Novel molecular mechanisms and biomarkers underlying IBD pathology.

Overall design

The Mount Sinai Crohn's and Colitis registry (MSCCR) is a prospective cross-sectional cohort consisting of adult IBD patients and controls. Blood RNA sequencing (RNA-Seq) data were generated on whole blood sampled at the time of the participant’s endoscopy visit which also included detailed clinical, histological and endoscopic assessments.

Source Evidence

4 sources
Source Contribution Status
GEO

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Sample records
1030 GSM samples
 Primary source
recount3

Planned trusted source for processed count availability.

 No match found
Expression Atlas

Planned source for curated expression experiment links.

 No match found
PubMed

Primary GEO citations and related PubMed articles that mention this dataset.

4 linked publications 4 DOIs

Primary publication

  1. Biopsy and blood-based molecular biomarker of inflammation in IBD. Gut, 2023

Related publications

  1. EPOR activation attenuates colitis via enhancing LC3B-dependent apoptotic cell clearance. Immunology, 2025
  2. Identifying inflammatory bowel disease subtypes: a comprehensive exploration of transcriptomic data and machine learning-based approaches. Therapeutic advances in gastroenterology, 2025
  3. Shared Immune Associations Between COVID-19 and Inflammatory Bowel Disease: A Cross-Sectional Observational Study in Shanghai, China. Journal of inflammation research, 2024
Available

Metadata Quality Components

Persisted metadata quality

100 pts
Clarity
100%
Weight
100 pts

Sample source clarity: All samples have source metadata and clear GSE/GSM accessions. Group clarity: Rule-based grouping found both case and control samples. Disease clarity: Disease or condition metadata normalized. Tissue clarity: Anatomical source metadata normalized. Treatment clarity: No unclear treatment split detected in the sample metadata. Replicate clarity: No pooled sample or technical replicate flags detected. Data availability clarity: Dataset-level processed or raw data availability is explicit.

Analysis Readiness

Ready after review
100% DE readiness

Contrast completeness

25/25 pts

Both case and control groups are present in the proposed grouping.

Minimum group size

20/20 pts

Each contrast group has at least 2 samples.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

10/10 pts

No dataset warnings are present.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

No readiness blockers detected.

Next Steps

  • Verify the proposed sample assignments and case-versus-control comparison against the GEO metadata before using them in DESeq2 or another differential-expression tool.
  • Confirm processed count files and sample identifiers match the exported metadata.

Analysis Preparation Checklist

5/6 ready

Group labels reviewed

Needs review

Siftome proposed case and control labels, but no reviewer confirmation is stored yet.

Open the sample grouping CSV and confirm group labels before analysis.

Minimum sample count met

Ready

Both groups meet the minimum of 2 samples.

Confirm whether the cohort is large enough for the intended statistical analysis.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Standard analyst review

Proceed only after the analyst confirms grouping, exclusions, and source files.

By Siftome standards, no expert review was triggered.

Why This Is Ranked Here

Tumor vs normal
Not suitable Dataset does not meet the current suitability threshold.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

  • Disease context Crohn's disease, inflammatory bowel disease, ulcerative colitis Disease context came from Normalization rules.
  • Likely case group Ulcerative colitis 821 samples
  • Likely control group Control 209 samples

Intent Interpretation

  • Downgrade or exclusion reason Downgraded for tissue search because it is a biofluid cohort. Derived from current-intent ranking reasons.

Ranking Facts

Supporting evidence

  • Comparison: Disease/model vs control. Specimen: Biofluid. Comparison suitability: 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Crohn's disease, Inflammatory bowel disease, Ulcerative colitis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 4 publications; 4 DOIs available: PMID 36109152, PMID 37204242, PMID 38558943, PMID 40808866.
  • Publication context: Biopsy and blood-based molecular biomarker of inflammation in IBD.. Gut, 2023. PMID 36109152. DOI 10.1136/gutjnl-2021-326451.
  • Publication context: EPOR activation attenuates colitis via enhancing LC3B-dependent apoptotic cell clearance.. Immunology, 2025. PMID 37204242. DOI 10.1111/imm.13660.
  • Publication context: Shared Immune Associations Between COVID-19 and Inflammatory Bowel Disease: A Cross-Sectional Observational Study in Shanghai, China.. Journal of inflammation research, 2024. PMID 38558943. DOI 10.2147/JIR.S449746.
  • Publication context: 1 additional linked PubMed publications are available.

Cautions

  • Downgraded for tissue search because it is a biofluid cohort.
  • Disease/control design without a tumor/normal comparison is outside tumor/normal triage.
  • Blood, plasma, or serum cohort downgraded because this ranking targets tissue tumor-vs-normal comparisons.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

No dataset warnings

Normalized Fields

showing 500 of 3485 fields

Sample Group Preview

showing 100 of 1030 preview rows Show Hide
Study totals: Case 821 | Control 209 | Unassigned 0 | Excluded 0 | Ambiguous 0 showing 100 of 1030 preview rows
Group Role Accession Title Source / characteristics Reason
Ulcerative colitis Case GSM6039312 MSCCR_reGRID_1, UC participants Blood Study_eligibility_age_at_endo: 44; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -1.73304477172605; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 1; Max_ghas_sum7: 2; Max_nancy: 0; Endoremiss: 1; Historemiss: 0 Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039313 MSCCR_reGRID_3, CD participants Blood Study_eligibility_age_at_endo: 58; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -0.380663212668861; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 10; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 1; Historemiss: 1 Case marker detected.
Inflammatory bowel disease Case GSM6039314 MSCCR_reGRID_4, CD participants Blood Study_eligibility_age_at_endo: 24; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.01634787156203; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Moderate; Ibdsescd_totalsescd: 9; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 0; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 5; Max_nancy: 3; Endoremiss: 0; Historemiss: 0 Case marker detected.
Ulcerative colitis Case GSM6039315 MSCCR_reGRID_5, UC participants Blood Study_eligibility_age_at_endo: 73; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.56331180341542; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Severe; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 3; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 0; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: 0; Historemiss: 0 Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039316 MSCCR_reGRID_6, UC participants Blood Study_eligibility_age_at_endo: 66; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 8.18393306942549; Crp_jjmgl_log2: -2.03281153285524; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 3; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039317 MSCCR_reGRID_7, CD participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 5.37677657188298; Crp_jjmgl_log2: 1.59094902639306; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 1; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 13; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Case marker detected.
Inflammatory bowel disease Case GSM6039318 MSCCR_reGRID_9, CD participants Blood Study_eligibility_age_at_endo: 49; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.92761473632138; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 5; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Case marker detected.
Inflammatory bowel disease Case GSM6039319 MSCCR_reGRID_10, CD participants Blood Study_eligibility_age_at_endo: 60; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 4.05398016818765; Crp_jjmgl_log2: 1.43649047297647; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 10; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Case marker detected.
Ulcerative colitis Case GSM6039320 MSCCR_reGRID_11, UC participants Blood Study_eligibility_age_at_endo: 45; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 0.831877241191673; Crp_jjmgl_log2: 2.21174498087544; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 2; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039321 MSCCR_reGRID_12, UC participants Blood Study_eligibility_age_at_endo: 71; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.34453203189906; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 1; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 1; Historemiss: 1 Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039322 MSCCR_reGRID_13, CD participants Blood Study_eligibility_age_at_endo: 33; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 7.92864229159226; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Severe; Ibdsescd_totalsescd: 25; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 4; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 2; Max_nancy: 0; Endoremiss: 0; Historemiss: 1 Case marker detected.
Ulcerative colitis Case GSM6039323 MSCCR_reGRID_14, UC participants Blood Study_eligibility_age_at_endo: 44; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: -1.55639334852439; Crp_jjmgl_log2: -0.817677217010208; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 0; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039324 MSCCR_reGRID_15, CD participants Blood Study_eligibility_age_at_endo: 31; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.33505991121037; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 1; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 6; Max_nancy: 3; Endoremiss: 1; Historemiss: 0 Case marker detected.
Inflammatory bowel disease Case GSM6039325 MSCCR_reGRID_17, CD participants Blood Study_eligibility_age_at_endo: 26; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.20474318539999; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: 3; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 4; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 6; Max_nancy: 2; Endoremiss: 0; Historemiss: 0 Case marker detected.
Inflammatory bowel disease Case GSM6039326 MSCCR_reGRID_18, CD participants Blood Study_eligibility_age_at_endo: 66; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.756007449357517; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 16; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Case marker detected.
Inflammatory bowel disease Case GSM6039327 MSCCR_reGRID_19, CD participants Blood Study_eligibility_age_at_endo: 44; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 5.48574882137778; Crp_jjmgl_log2: 1.64453384658324; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: Moderate; Ibdsescd_totalsescd: 10; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 7; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Case marker detected.
Inflammatory bowel disease Case GSM6039328 MSCCR_reGRID_22, CD participants Blood Study_eligibility_age_at_endo: 22; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 7.26500549334373; Crp_jjmgl_log2: 5.77718072045503; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: Severe; Ibdsescd_totalsescd: 26; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 7; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 6; Max_nancy: 2; Endoremiss: 0; Historemiss: 0 Case marker detected.
Ulcerative colitis Case GSM6039329 MSCCR_reGRID_23, UC participants Blood Study_eligibility_age_at_endo: 33; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -1.50167034151491; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 3; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039330 MSCCR_reGRID_24, UC participants Blood Study_eligibility_age_at_endo: 76; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 7.60599798023252; Crp_jjmgl_log2: 7.49821090081062; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Severe; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 3; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 9; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 0; Historemiss: 1 Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039331 MSCCR_reGRID_25, CD participants Blood Study_eligibility_age_at_endo: 24; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -0.566528120922922; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 0; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 1; Historemiss: 1 Case marker detected.
Inflammatory bowel disease Case GSM6039332 MSCCR_reGRID_27, CD participants Blood Study_eligibility_age_at_endo: 39; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 4.84398384404833; Crp_jjmgl_log2: 0.137516750579745; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 7; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 1; Historemiss: 1 Case marker detected.
Inflammatory bowel disease Case GSM6039333 MSCCR_reGRID_28, CD participants Blood Study_eligibility_age_at_endo: 33; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.070132708703722; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 2; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Case marker detected.
Inflammatory bowel disease Case GSM6039334 MSCCR_reGRID_29, CD participants Blood Study_eligibility_age_at_endo: 42; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.10802011485218; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: 4; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 2; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 2; Max_nancy: 1; Endoremiss: 0; Historemiss: 0 Case marker detected.
Inflammatory bowel disease Case GSM6039335 MSCCR_reGRID_31, CD participants Blood Study_eligibility_age_at_endo: 33; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -0.626981432698716; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 3; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Case marker detected.
Inflammatory bowel disease Case GSM6039336 MSCCR_reGRID_32, CD participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.395175212349157; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: 5; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 6; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Case marker detected.
Ulcerative colitis Case GSM6039337 MSCCR_reGRID_33, UC participants Blood Study_eligibility_age_at_endo: 55; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 5.18982455888002; Crp_jjmgl_log2: 3.38235678539555; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Moderate; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 2; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 4; Max_ghas_sum7: 7; Max_nancy: 2; Endoremiss: 0; Historemiss: 0 Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039338 MSCCR_reGRID_36, UC participants Blood Study_eligibility_age_at_endo: 30; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 6.96139181179108; Crp_jjmgl_log2: NA; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 2; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 0; Historemiss: 1 Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039339 MSCCR_reGRID_37, CD participants Blood Study_eligibility_age_at_endo: 32; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.79373030782561; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Moderate; Ibdsescd_totalsescd: 8; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 0; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 0; Historemiss: 1 Case marker detected.
Ulcerative colitis Case GSM6039340 MSCCR_reGRID_38, UC participants Blood Study_eligibility_age_at_endo: 30; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 3.66106547980695; Crp_jjmgl_log2: 1.01654616297215; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 1; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039341 MSCCR_reGRID_39, UC participants Blood Study_eligibility_age_at_endo: 26; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 7.40497122358917; Crp_jjmgl_log2: 1.83162997327723; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 3; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039342 MSCCR_reGRID_41, CD participants Blood Study_eligibility_age_at_endo: 26; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -1.59936069623465; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 6; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 3; Max_nancy: 2; Endoremiss: 1; Historemiss: 0 Case marker detected.
Ulcerative colitis Case GSM6039343 MSCCR_reGRID_43, UC participants Blood Study_eligibility_age_at_endo: 29; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.78573101856715; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 0; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: 0; Historemiss: 0 Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039344 MSCCR_reGRID_47, CD participants Blood Study_eligibility_age_at_endo: 39; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 5.70095875887396; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: 3; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 13; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: 0; Historemiss: 1 Case marker detected.
Ulcerative colitis Case GSM6039345 MSCCR_reGRID_50, UC participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -0.449903259594897; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 0; Max_ghas_sum7: 3; Max_nancy: 2; Endoremiss: 1; Historemiss: 0 Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039346 MSCCR_reGRID_52, CD participants Blood Study_eligibility_age_at_endo: 64; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -2.73760410876338; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: 3; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 2; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Case marker detected.
Ulcerative colitis Case GSM6039347 MSCCR_reGRID_53, UC participants Blood Study_eligibility_age_at_endo: 59; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 5.70154905694307; Crp_jjmgl_log2: -0.11651971296513; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 3; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039348 MSCCR_reGRID_54, CD participants Blood Study_eligibility_age_at_endo: 66; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 2.77188557851537; Crp_jjmgl_log2: NA; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: 6; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 10; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Case marker detected.
Ulcerative colitis Case GSM6039349 MSCCR_reGRID_55, UC participants Blood Study_eligibility_age_at_endo: 31; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.28471363111547; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 0; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 1; Historemiss: 1 Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039350 MSCCR_reGRID_56, UC participants Blood Study_eligibility_age_at_endo: 52; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.295985357278583; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 2; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039351 MSCCR_reGRID_57, CD participants Blood Study_eligibility_age_at_endo: 26; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.09766001326082; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 9; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: 1; Historemiss: 1 Case marker detected.
Inflammatory bowel disease Case GSM6039352 MSCCR_reGRID_59, CD participants Blood Study_eligibility_age_at_endo: 33; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 2.37573453858316; Crp_jjmgl_log2: 2.26420520844677; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 0; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 1; Max_nancy: 2; Endoremiss: 1; Historemiss: 0 Case marker detected.
Ulcerative colitis Case GSM6039353 MSCCR_reGRID_63, UC participants Blood Study_eligibility_age_at_endo: 61; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.05692901037828; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Mild; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 1; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 6; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 0; Historemiss: NA Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039354 MSCCR_reGRID_64, UC participants Blood Study_eligibility_age_at_endo: 35; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.0749539858711973; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 0; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039355 MSCCR_reGRID_65, UC participants Blood Study_eligibility_age_at_endo: 51; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.27916614095037; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 5; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Explicit sample label case marker detected.
Ulcerative colitis Case GSM6039356 MSCCR_reGRID_66, UC participants Blood Study_eligibility_age_at_endo: 41; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.24417101039347; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 6; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039357 MSCCR_reGRID_68, CD participants Blood Study_eligibility_age_at_endo: 24; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 0.84799690655495; Crp_jjmgl_log2: 7.47022806635007; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 2; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: 1; Historemiss: 1 Case marker detected.
Inflammatory bowel disease Case GSM6039358 MSCCR_reGRID_70, CD participants Blood Study_eligibility_age_at_endo: 47; Demographics_gender: Female; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: 1.34482849699744; Crp_jjmgl_log2: 3.09296323360741; Ibd_clinicianmeasure_inactive_active: Active; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: 0; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 11; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: 1; Historemiss: NA Case marker detected.
Ulcerative colitis Case GSM6039359 MSCCR_reGRID_71, UC participants Blood Study_eligibility_age_at_endo: 24; Demographics_gender: Male; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.53887616014559; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Inactive; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 0; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 1; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: 1; Historemiss: 0 Explicit sample label case marker detected.
Inflammatory bowel disease Case GSM6039360 MSCCR_reGRID_72, CD participants Blood Study_eligibility_age_at_endo: 26; Demographics_gender: Male; Ibd_disease: CD; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 6.52585955420893; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Moderate; Ibdsescd_totalsescd: 7; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: 3; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 7; Max_nancy: 2; Endoremiss: 0; Historemiss: 0 Case marker detected.
Ulcerative colitis Case GSM6039361 MSCCR_reGRID_75, UC participants Blood Study_eligibility_age_at_endo: 64; Demographics_gender: Female; Ibd_disease: UC; Diseasebi: IBD; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 4.61449882658432; Ibd_clinicianmeasure_inactive_active: Inactive; Ibd_endoseverity_4levels: Severe; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: 3; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: 1; Max_ghas_sum7: 6; Max_nancy: 2; Endoremiss: 0; Historemiss: 0 Explicit sample label case marker detected.
771 additional case samples are hidden from this preview.
Control Control GSM6039422 MSCCR_reGRID_163, Control participants Blood Study_eligibility_age_at_endo: 53; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.05341568172183; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039550 MSCCR_reGRID_347, Control participants Blood Study_eligibility_age_at_endo: 60; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -1.17572833193073; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039650 MSCCR_reGRID_477, Control participants Blood Study_eligibility_age_at_endo: 50; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.55120749669863; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 5; Max_nancy: 2; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039657 MSCCR_reGRID_489, Control participants Blood Study_eligibility_age_at_endo: 66; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.43985461768797; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039665 MSCCR_reGRID_500, Control participants Blood Study_eligibility_age_at_endo: 55; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.858827052205547; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039670 MSCCR_reGRID_505, Control participants Blood Study_eligibility_age_at_endo: 51; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.75109873464225; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039672 MSCCR_reGRID_508, Control participants Blood Study_eligibility_age_at_endo: 40; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: NA; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039679 MSCCR_reGRID_522, Control participants Blood Study_eligibility_age_at_endo: 25; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -4.17565253266636; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039681 MSCCR_reGRID_525, Control participants Blood Study_eligibility_age_at_endo: 60; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.05918759749469; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039686 MSCCR_reGRID_535, Control participants Blood Study_eligibility_age_at_endo: 26; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.28139215265731; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039687 MSCCR_reGRID_538, Control participants Blood Study_eligibility_age_at_endo: 52; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.497454960599494; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039689 MSCCR_reGRID_540, Control participants Blood Study_eligibility_age_at_endo: 70; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: 2.78659636189081; Crp_jjmgl_log2: 3.6989541106838; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039692 MSCCR_reGRID_544, Control participants Blood Study_eligibility_age_at_endo: 68; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.61735382427592; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039695 MSCCR_reGRID_551, Control participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 6.02412882777307; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039697 MSCCR_reGRID_553, Control participants Blood Study_eligibility_age_at_endo: 64; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.517652623581501; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 4; Max_nancy: 2; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039701 MSCCR_reGRID_563, Control participants Blood Study_eligibility_age_at_endo: 70; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -0.708599225593879; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039702 MSCCR_reGRID_566, Control participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -1.67193947784803; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039705 MSCCR_reGRID_570, Control participants Blood Study_eligibility_age_at_endo: 64; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.34524878428408; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039710 MSCCR_reGRID_582, Control participants Blood Study_eligibility_age_at_endo: 52; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: 1.78240856492737; Crp_jjmgl_log2: 4.55847307916338; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039712 MSCCR_reGRID_584, Control participants Blood Study_eligibility_age_at_endo: 60; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.24392691757876; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039713 MSCCR_reGRID_586, Control participants Blood Study_eligibility_age_at_endo: 51; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.13868651052608; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039718 MSCCR_reGRID_592, Control participants Blood Study_eligibility_age_at_endo: 50; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.62501999940332; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039720 MSCCR_reGRID_594, Control participants Blood Study_eligibility_age_at_endo: 34; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.164228080131142; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039722 MSCCR_reGRID_596, Control participants Blood Study_eligibility_age_at_endo: 52; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 0.640264256028596; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039723 MSCCR_reGRID_600, Control participants Blood Study_eligibility_age_at_endo: 55; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.11099678614596; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039729 MSCCR_reGRID_606, Control participants Blood Study_eligibility_age_at_endo: 48; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.7647757933478; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039731 MSCCR_reGRID_608, Control participants Blood Study_eligibility_age_at_endo: 64; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.72349449696344; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039733 MSCCR_reGRID_610, Control participants Blood Study_eligibility_age_at_endo: 53; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 4.27468643102878; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039737 MSCCR_reGRID_614, Control participants Blood Study_eligibility_age_at_endo: 41; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: 2.06350294230616; Crp_jjmgl_log2: 0.61031386986262; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039739 MSCCR_reGRID_616, Control participants Blood Study_eligibility_age_at_endo: 24; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -3.12367598228747; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039740 MSCCR_reGRID_618, Control participants Blood Study_eligibility_age_at_endo: 58; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.58559898074637; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039741 MSCCR_reGRID_619, Control participants Blood Study_eligibility_age_at_endo: 50; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.19671068529585; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 1; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039742 MSCCR_reGRID_620, Control participants Blood Study_eligibility_age_at_endo: 59; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: 0.807354922057604; Crp_jjmgl_log2: 1.32554445019424; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039747 MSCCR_reGRID_628, Control participants Blood Study_eligibility_age_at_endo: 45; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.47996094608969; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039750 MSCCR_reGRID_632, Control participants Blood Study_eligibility_age_at_endo: 51; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.82503726803308; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 0; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039753 MSCCR_reGRID_636, Control participants Blood Study_eligibility_age_at_endo: 61; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.29865702021732; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039759 MSCCR_reGRID_644, Control participants Blood Study_eligibility_age_at_endo: 42; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.85627171682171; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039760 MSCCR_reGRID_645, Control participants Blood Study_eligibility_age_at_endo: 49; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.57856683086344; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039761 MSCCR_reGRID_646, Control participants Blood Study_eligibility_age_at_endo: 64; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: -4.01166769701354; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039762 MSCCR_reGRID_647, Control participants Blood Study_eligibility_age_at_endo: 52; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 4.00912447709963; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039763 MSCCR_reGRID_648, Control participants Blood Study_eligibility_age_at_endo: 56; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.02242977531666; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039764 MSCCR_reGRID_649, Control participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 4.89305558801056; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039765 MSCCR_reGRID_651, Control participants Blood Study_eligibility_age_at_endo: 56; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 3.22543156022218; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: 2; Max_nancy: 0; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039775 MSCCR_reGRID_664, Control participants Blood Study_eligibility_age_at_endo: 68; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: 0.37851162325373; Crp_jjmgl_log2: -0.0219062516201552; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039776 MSCCR_reGRID_666, Control participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.36466616100786; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039777 MSCCR_reGRID_667, Control participants Blood Study_eligibility_age_at_endo: 41; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: -0.0588936890535686; Crp_jjmgl_log2: -3.93425573877936; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039778 MSCCR_reGRID_668, Control participants Blood Study_eligibility_age_at_endo: 52; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.80660524703276; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039779 MSCCR_reGRID_670, Control participants Blood Study_eligibility_age_at_endo: 57; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 2.76265298342846; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039780 MSCCR_reGRID_672, Control participants Blood Study_eligibility_age_at_endo: 62; Demographics_gender: Female; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: NA; Crp_jjmgl_log2: 1.60873983176485; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
Control Control GSM6039781 MSCCR_reGRID_673, Control participants Blood Study_eligibility_age_at_endo: 62; Demographics_gender: Male; Ibd_disease: Control; Diseasebi: Control; Log2_fecalcalpro_mgperg: 3.5385381636298; Crp_jjmgl_log2: 0.638918926869185; Ibd_clinicianmeasure_inactive_active: NA; Ibd_endoseverity_4levels: NA; Ibdsescd_totalsescd: NA; Ibdmesuc_mayo_score: NA; Harveybradshawindex_hbi_score: NA; Colitisactivityindex_sccai: NA; Max_ghas_sum7: NA; Max_nancy: NA; Endoremiss: NA; Historemiss: NA Sample-local control marker detected.
159 additional control samples are hidden from this preview.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.